PT  - JOURNAL ARTICLE
AU  - Wyllie, Anne L.
AU  - Fournier, John
AU  - Casanovas-Massana, Arnau
AU  - Campbell, Melissa
AU  - Tokuyama, Maria
AU  - Vijayakumar, Pavithra
AU  - Geng, Bertie
AU  - Muenker, M. Catherine
AU  - Moore, Adam J.
AU  - Vogels, Chantal B.F.
AU  - Petrone, Mary E.
AU  - Ott, Isabel M.
AU  - Lu, Peiwen
AU  - Venkataraman, Arvind
AU  - Lu-Culligan, Alice
AU  - Klein, Jonathan
AU  - Earnest, Rebecca
AU  - Simonov, Michael
AU  - Datta, Rupak
AU  - Handoko, Ryan
AU  - Naushad, Nida
AU  - Sewanan, Lorenzo R.
AU  - Valdez, Jordan
AU  - White, Elizabeth B.
AU  - Lapidus, Sarah
AU  - Kalinich, Chaney C.
AU  - Jiang, Xiaodong
AU  - Kim, Daniel J.
AU  - Kudo, Eriko
AU  - Linehan, Melissa
AU  - Mao, Tianyang
AU  - Moriyama, Miyu
AU  - Oh, Ji Eun
AU  - Park, Annsea
AU  - Silva, Julio
AU  - Song, Eric
AU  - Takahashi, Takehiro
AU  - Taura, Manabu
AU  - Weizman, Orr-El
AU  - Wong, Patrick
AU  - Yang, Yexin
AU  - Bermejo, Santos
AU  - Odio, Camila
AU  - Omer, Saad B.
AU  - Dela Cruz, Charles S.
AU  - Farhadian, Shelli
AU  - Martinello, Richard A.
AU  - Iwasaki, Akiko
AU  - Grubaugh, Nathan D.
AU  - Ko, Albert I.
TI  - Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs
AID  - 10.1101/2020.04.16.20067835
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.16.20067835
4099  - http://medrxiv.org/content/early/2020/04/22/2020.04.16.20067835.short
4100  - http://medrxiv.org/content/early/2020/04/22/2020.04.16.20067835.full
AB  - Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing COVID-19 pandemic. The current gold standard for COVID-19 diagnosis is real-time RT-PCR detection of SARS-CoV-2 from nasopharyngeal swabs. Low sensitivity, exposure risks to healthcare workers, and global shortages of swabs and personal protective equipment, however, necessitate the validation of new diagnostic approaches. Saliva is a promising candidate for SARS-CoV-2 diagnostics because (1) collection is minimally invasive and can reliably be self-administered and (2) saliva has exhibited comparable sensitivity to nasopharyngeal swabs in detection of other respiratory pathogens, including endemic human coronaviruses, in previous studies. To validate the use of saliva for SARS-CoV-2 detection, we tested nasopharyngeal and saliva samples from confirmed COVID-19 patients and self-collected samples from healthcare workers on COVID-19 wards. When we compared SARS-CoV-2 detection from patient-matched nasopharyngeal and saliva samples, we found that saliva yielded greater detection sensitivity and consistency throughout the course of infection. Furthermore, we report less variability in self-sample collection of saliva. Taken together, our findings demonstrate that saliva is a viable and more sensitive alternative to nasopharyngeal swabs and could enable at-home self-administered sample collection for accurate large-scale SARS-CoV-2 testing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding sources had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding authors had full access to all data in the study and had final responsibility for the decision to submit for publication.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated and/or analysed during the current study are available from the corresponding author on reasonable request.